2018-2023 UK Capecitabine Market Report (Status and Outlook)

Publisher Name :
Date: 07-Jun-2018
No. of pages: 87

In 2017, the Capecitabine market size was xx million USD in UK, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.

In UK market, the top players include

- Roche

- Teva

- Mylan

- Hikma

- Hengrui Medicine

- Cipla

- Reliance Group

- Hetero

Split by product types/category, covering

- 500 mg

- 150 mg

Split by applications/end use industries, covers

- Breast Cancer

- Colorectal cancer

- Stomach Cancer

2018-2023 UK Capecitabine Market Report (Status and Outlook)

Table of Contents

2018-2023 UK Capecitabine Market Report (Status and Outlook)
1 Capecitabine Market Overview
1.1 Product Overview and Scope of Capecitabine
1.2 Capecitabine Market Segment by Types
1.2.1 UK Capecitabine Sales Present Situation and Outlook by Types (2013-2023)
1.2.2 UK Capecitabine Sales Market Share by Types in 2017
1.2.3 500 mg
1.2.3.1 Major Players of 500 mg
1.2.4 150 mg
1.2.4.1 Major Players of 150 mg
1.3 UK Capecitabine Market Segment by Applications/End Use Industries
1.3.1 UK Capecitabine Sales Present Situation and Outlook by Applications/End Industrials (2013-2023)
1.3.2 UK Capecitabine Sales Market Share by Applications in 2017
1.3.2 Breast Cancer
1.3.3 Colorectal cancer
1.3.4 Stomach Cancer
1.4 UK Capecitabine Overview and Market Size (Value) (2013-2023)
1.4.1 UK Market Capecitabine Overview
1.4.2 UK Capecitabine Market Size (Value and Volume) Status and Forecast (2013-2023)
2 UK Capecitabine Sales, Revenue (Value) and Market Share by Players
2.1 UK Capecitabine Sales and Market Share by Players (2013-2018)
2.2 UK Capecitabine Revenue and Market Share by Players (2013-2018)
2.3 UK Capecitabine Average Price by Players in 2017
2.4 UK Capecitabine Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 Capecitabine Market Competitive Situation and Trends
2.5.1 Capecitabine Market Concentration Rate
2.5.2 Capecitabine Market Share of Top 3 and Top 5 Players in 2017
2.5.3 Mergers & Acquisitions, Expansion
3 UK Capecitabine Sales, Revenue (Value) by Type and Application (2013-2018)
3.1 UK Capecitabine Sales, Revenue, Market Share and Price by Type (2013-2018)
3.1.1 UK Capecitabine Sales and Market Share by Type (2013-2018)
3.1.2 UK Capecitabine Revenue and Market Share by Type (2013-2018)
3.1.3 UK Capecitabine Price by Type (2013-2018)
3.2 UK Capecitabine Sales and Market Share by Application (2013-2018)
3.3 UK Market Capecitabine Sales, Revenue (Million USD), Price and Gross Margin (2013-2018)
4 UK Capecitabine Players Profiles and Sales Data
4.1 Roche
4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.1.2 Capecitabine Product Types, Application and Specification
4.1.2.1 Type 1
4.1.2.2 Type 2
4.1.3 Roche Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.1.4 Main Business/Business Overview
4.1.5 Roche News
4.2 Teva
4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.2.2 Capecitabine Product Types, Application and Specification
4.2.2.1 Type 1
4.2.2.2 Type 2
4.2.3 Teva Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.2.4 Main Business/Business Overview
4.2.5 Teva News
4.3 Mylan
4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.3.2 Capecitabine Product Types, Application and Specification
4.3.2.1 Type 1
4.3.2.2 Type 2
4.3.3 Mylan Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.3.4 Main Business/Business Overview
4.3.5 Mylan News
4.4 Hikma
4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.4.2 Capecitabine Product Types, Application and Specification
4.4.2.1 Type 1
4.4.2.2 Type 2
4.4.3 Hikma Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.4.4 Main Business/Business Overview
4.4.5 Hikma News
4.5 Hengrui Medicine
4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.5.2 Capecitabine Product Types, Application and Specification
4.5.2.1 Type 1
4.5.2.2 Type 2
4.5.3 Hengrui Medicine Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.5.4 Main Business/Business Overview
4.5.5 Hengrui Medicine News
4.6 Cipla
4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.6.2 Capecitabine Product Types, Application and Specification
4.6.2.1 Type 1
4.6.2.2 Type 2
4.6.3 Cipla Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.6.4 Main Business/Business Overview
4.6.5 Cipla News
4.7 Reliance Group
4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.7.2 Capecitabine Product Types, Application and Specification
4.7.2.1 Type 1
4.7.2.2 Type 2
4.7.3 Reliance Group Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.7.4 Main Business/Business Overview
4.7.5 Reliance Group News
4.8 Hetero
4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.8.2 Capecitabine Product Types, Application and Specification
4.8.2.1 Type 1
4.8.2.2 Type 2
4.8.3 Hetero Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.8.4 Main Business/Business Overview
4.8.5 Hetero News
5 UK Capecitabine Market Forecast (2018-2023)
5.1 UK Capecitabine Sales, Revenue and Price Forecast (2018-2023)
5.1.1 UK Capecitabine Sales and Growth Rate Forecast (2018-2023)
5.1.2 UK Capecitabine Revenue and Growth Rate Forecast (2018-2023)
5.1.3 UK Capecitabine Price Trend Forecast (2018-2023)
5.2 UK Capecitabine Sales Forecast by Type (2018-2023)
5.3 UK Capecitabine Sales Forecast by Application (2018-2023)
6 Production Cost Analysis of Capecitabine
6.1 Main Raw Materials of Capecitabine
6.1.1 List of Capecitabine Main Raw Materials
6.1.2 Capecitabine Main Raw Materials Price Analysis
6.1.3 Capecitabine Raw Materials Major Suppliers
6.1.4 Capecitabine Main Raw Materials Market Concentration Rate
6.2 Production Cost Structure of Capecitabine
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Production Expenses
6.3 Capecitabine Manufacturing Process/Method
7 Value Chain, Purchasing Strategy and Downstream Buyers
7.1 Capecitabine Value Chain Analysis
7.2 Upstream Raw Materials Purchasing
7.3 Raw Materials Sources of Capecitabine Major Players in 2017
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Sales Channel
8.1.1 Direct Sales
8.1.2 Indirect Sales
8.1.3 Sales Channel Development Trend
8.2 Product Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Capecitabine Distributors/Traders List in UK
9 Market Influences Factors Analysis
9.1 Changes from the Related Industries
9.2 Substitutes Threat
9.3 Customer Preference Change
9.4 Economic/Political Environmental Change
9.5 Upstream and Downstream Fluctuation
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Data Source

List of Tables and Figures

Figure Picture of Capecitabine
Table Product Specifications of Capecitabine
Figure UK Capecitabine Sales (volume) for Each Type (2013-2023)
Figure UK Capecitabine Sales Market Share by Types in 2017
Table Types of Capecitabine
Figure Product Picture of 500 mg
Table Major Players of 500 mg
Figure Product Picture of 150 mg
Table Major Players of 150 mg
Figure UK Capecitabine Sales Present Situation and Outlook by Applications (2013-2023)
Figure UK Capecitabine Sales Market Share by Applications in 2017
Table Applications of Capecitabine
Figure Breast Cancer Examples
Figure Colorectal cancer Examples
Figure Stomach Cancer Examples
Figure UK Capecitabine Revenue (Million USD) Status and Forecast (2013-2023)
Figure UK Capecitabine Sales (Volume) Status and Forecast (2013-2023)
Table UK Capecitabine Sales by Players (2013-2018)
Table UK Capecitabine Sales Market Share (%) by Players (2013-2018)
Figure UK Capecitabine Sales Market Share by Players in 2016
Figure UK Capecitabine Sales Market Share by Players in 2017
Table UK Capecitabine Revenue (Million USD) by Players (2013-2018)
Table UK Capecitabine Revenue Market Share (%) by Players (2013-2018)
Figure UK Capecitabine Revenue Market Share by Players in 2016
Figure UK Capecitabine Revenue Market Share by Players in 2017
Figure UK Capecitabine Average Price by Players in 2017
Table UK Capecitabine Manufacturing Base Distribution and Sales Area by Players
Table Players Capecitabine Product Types
Figure Capecitabine Market Share of Top 3 Players in 2017
Figure Capecitabine Market Share of Top 5 Players in 2017
Table UK Capecitabine Sales by Type (2013-2018)
Table UK Capecitabine Sales Market Share by Type (2013-2018)
Figure UK Capecitabine Sales Market Share by Type in 2013
Figure UK Capecitabine Sales Market Share by Type in 2017
Table UK Capecitabine Revenue (Million USD) by Type (2013-2018)
Table UK Capecitabine Revenue Market Share by Type (2013-2018)
Figure UK Capecitabine Revenue Market Share by Type in 2013
Figure UK Capecitabine Revenue Market Share by Type in 2017
Table UK Capecitabine Price by Type (2013-2018)
Table UK Capecitabine Sales by Application (2013-2018)
Table UK Capecitabine Sales Market Share by Application (2013-2018)
Figure UK Capecitabine Sales Market Share by Application (2013-2018)
Figure UK Capecitabine Sales Market Share by Application in 2017
Table UK Market Capecitabine Sales, Revenue (Million USD), Price and Gross Margin (2013-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Capecitabine Market Share (2012-2017)
Table Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Teva Capecitabine Market Share (2012-2017)
Table Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Mylan Capecitabine Market Share (2012-2017)
Table Hikma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hikma Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hikma Capecitabine Market Share (2012-2017)
Table Hengrui Medicine Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hengrui Medicine Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hengrui Medicine Capecitabine Market Share (2012-2017)
Table Cipla Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cipla Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Cipla Capecitabine Market Share (2012-2017)
Table Reliance Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Reliance Group Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Reliance Group Capecitabine Market Share (2012-2017)
Table Hetero Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hetero Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hetero Capecitabine Market Share (2012-2017)
Figure UK Capecitabine Sales and Growth Rate Forecast (2018-2023)
Figure UK Capecitabine Revenue and Growth Rate Forecast (2018-2023)
Figure UK Capecitabine Price Trend Forecast (2018-2023)
Table UK Capecitabine Sales Forecast by Type (2018-2023)
Figure UK Capecitabine Sales Market Share Forecast by Type (2018-2023)
Figure UK Capecitabine Sales Market Share Forecast by Type in 2023
Table UK Capecitabine Sales Forecast by Application (2018-2023)
Figure UK Capecitabine Sales Market Share Forecast by Application (2018-2023)
Figure UK Capecitabine Sales Market Share Forecast by Application in 2023
Table Production Base and Market Concentration Rate of Raw Material
Figure Capecitabine Main Raw Materials Price Trend
Table Capecitabine Raw Materials Major Suppliers List
Figure Production Cost Structure of Capecitabine
Figure Capecitabine Manufacturing Process/Method
Figure Capecitabine Value Chain Analysis
Table Raw Materials Sources of Capecitabine Major Players in 2017
Table Major Buyers of Capecitabine
Table Capecitabine Distributors/Traders List in UK
  • Global Hematological Malignancies Disease Market Insights, Forecast to 2025
    Published: 15-Nov-2018        Price: US 4900 Onwards        Pages: 105
    This report studies the global market size of Hematological Malignancies Disease in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hematological Malignancies Disease in these regions. This research report categorizes the global Hematological Malignancies Disease market by top players/brands, region, type and end user. This report also studies the global Hematological Malignancies Disease market status, ......
  • Global Erlotinib Hydrochloride Market Insights, Forecast to 2025
    Published: 14-Nov-2018        Price: US 4900 Onwards        Pages: 99
    This report presents the worldwide Erlotinib Hydrochloride market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. The Erlotinib Hydrochloride marke......
  • Global Polymer Drug Conjugates Market Data Survey Report 2025
    Published: 13-Nov-2018        Price: US 1500 Onwards        Pages: 80
    Summary The global Polymer Drug Conjugates market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Major Application Major Type Key manufacturers are included based on manufacturing sites, capacity and producti......
  • Global Oncology Drugs Market Insights, Forecast to 2025
    Published: 13-Nov-2018        Price: US 3900 Onwards        Pages: 119
    This report studies the global market size of Oncology Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oncology Drugs in these regions. This research report categorizes the global Oncology Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportu......
  • Global Lenalidomide Market Insights, Forecast to 2025
    Published: 13-Nov-2018        Price: US 3900 Onwards        Pages: 111
    This report studies the global market size of Lenalidomide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Lenalidomide in these regions. This research report categorizes the global Lenalidomide market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities......
  • Global Prostate Cancer Market Data Survey Report 2025
    Published: 12-Nov-2018        Price: US 1500 Onwards        Pages: 70
    Summary The global Prostate Cancer market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Major Application Major Type Key manufacturers are included based on manufacturing sites, capacity and production, prod......
  • Global Cancer Targeted Therapy Market Size, Status and Forecast 2018-2025
    Published: 09-Nov-2018        Price: US 3900 Onwards        Pages: 111
    This report focuses on the global Cancer Targeted Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Targeted Therapy development in United States, Europe and China. In 2017, the global Cancer Targeted Therapy market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. The key players covered in this study - Advaxis ......
  • Global Neuroendocrine Carcinoma Drugs Market Research Report 2018
    Published: 09-Nov-2018        Price: US 2900 Onwards        Pages: 115
    This report studies the global Neuroendocrine Carcinoma Drugs market status and forecast, categorizes the global Neuroendocrine Carcinoma Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Xiaflex - Novartis AG - Roche - Molecular......
  • Global Carmustine Market Insights, Forecast to 2025
    Published: 08-Nov-2018        Price: US 3900 Onwards        Pages: 119
    This report studies the global market size of Carmustine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Carmustine in these regions. This research report categorizes the global Carmustine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenge......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs